INVESTOR REMINDER: BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SHAREHOLDER CLASS ACTION DEADLINE- Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioMarin PharmaceuticalPRNewsWire • 11/20/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - BMRNNewsfile Corp • 11/19/21
BioMarin Receives FDA Approval for VOXZOGO™ (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth PlatesPRNewsWire • 11/19/21
ROSEN, A TOP RANKED LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BMRNNewsfile Corp • 11/17/21
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, RECAF and ONTFAccesswire • 11/16/21
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery PlatformPRNewsWire • 11/15/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HYZN, BMRN and TMCAccesswire • 11/14/21
BMRN Shareholder Alert: Rosen, Recognized Investor Counsel, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BMRNNewsfile Corp • 11/12/21
BioMarin Pharmaceutical Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against BioMarin PharmacPRNewsWire • 11/11/21
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the FirmBusiness Wire • 11/11/21
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, AMRN and RECAFAccesswire • 11/08/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, BMRN and AMRNAccesswire • 11/07/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Before Important December 22 Deadline in Securities Class Action – BMRNBusiness Wire • 11/06/21
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - BMRNPRNewsWire • 11/05/21
SHAREHOLDER ALERT: ZEV BMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 11/05/21
SHAREHOLDER ALERT: BMRN AMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 11/04/21
INVESTOR REMINDER: BIOMARIN PHARMACEUTICAL INC. (BMRN) SHAREHOLDER CLASS ACTION DEADLINE- Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.Newsfile Corp • 11/03/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, BMRN and HMLPAccesswire • 11/03/21
SHAREHOLDER ALERT: BMRN AMRN HMLP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 11/03/21
BioMarin: Voxzogo Approval Could Trigger A Lengthy Bull Run For Cash Rich BiotechSeeking Alpha • 11/01/21
Wall Street Analysts Believe BioMarin (BMRN) Could Rally 37%: Here's is How to TradeZacks Investment Research • 11/01/21
SHAREHOLDER ALERT: Robbins LLP Announces that BioMarin Pharmaceutical Inc. (BMRN) is Being Sued for Misleading ShareholdersBusiness Wire • 11/01/21
